Nov 24, 2025 01:25AM
Jun 23, 2025 01:50AM
Apr 29, 2025 06:00AM
Dec 2, 2024 01:30AM
Jun 24, 2024 01:55AM
Jun 11, 2024 11:40AM
Nov 29, 2023 12:50AM Prosus Accelerates Profitability Target and Delivers on Objectives
Aug 23, 2023 11:05AM
Jul 12, 2023 10:00AM
Jun 27, 2023 02:00AM
Jun 27, 2023 01:55AM
Jun 27, 2023 01:55AM
Nov 23, 2022 05:30AM
Aug 24, 2022 11:30AM  Prosus N.V.: Results of Annual General Meeting
Jun 27, 2022 01:15AM
Nov 22, 2021 01:00AM
Jun 21, 2021 02:14AM
Nov 23, 2020 12:45AM
Nov 16, 2020 11:14AM
Aug 7, 2020 03:26AM
Jun 29, 2020 11:50AM Prosus Delivers Solid Results for the Twelve Months Ended 31 March 2020
Apr 8, 2020 11:45AM
Jan 31, 2020 12:04PM
Dec 23, 2019 02:00AM
Dec 20, 2019 08:30AM
Dec 19, 2019 10:29AM
Dec 11, 2019 03:30AM
Dec 10, 2019 10:00AM Prosus: Update on Increased Cash Offer
Dec 10, 2019 02:02AM
Dec 9, 2019 10:48AM
Nov 25, 2019 02:26AM
Nov 22, 2019 08:23AM
Nov 20, 2019 06:07AM
Oct 22, 2019 06:36AM
Oct 22, 2019 03:39AM European stocks subdued by mixed corporate earnings and Brexit
Aug 2, 2012 08:10AM
Aug 1, 2012 06:41PM
Jul 20, 2012 04:11PM
Jul 17, 2012 06:06PM
Jul 16, 2012 12:24PM
Jul 16, 2012 10:11AM
May 8, 2012 07:31AM Par Pharmaceutical (PRX) Tops Q1 EPS by 8c
May 7, 2012 05:52PM
Feb 29, 2012 09:52AM
Feb 28, 2012 07:32AM
Jan 6, 2012 11:20AM
Nov 30, 2011 10:59AM
Nov 28, 2011 12:43PM
Nov 25, 2011 03:19PM Relational Investors Shows New 8.71% Stake in Par Pharmaceutical Cos., Inc. (PRX), Says Board Should Consider a Sale If Discount Persists
Nov 1, 2011 06:09PM

1,168,522 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All